• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Deciphera Pharmaceuticals Inc (NQ: DCPH )

    25.33 +0.05 (+0.20%)
    Streaming Delayed Price Updated: 11:47 AM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,043,706
    Open 25.23
    Bid (Size) 25.33 (9)
    Ask (Size) 25.34 (63)
    Prev. Close 25.28
    Today's Range 25.21 - 25.35
    52wk Range 9.900 - 25.40
    Shares Outstanding 58,041,410
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc. (Nasdaq - HCP), Heartland Financial, USA Inc. (Nasdaq - HTLF), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq -
    From Brodsky & Smith LLC
    Via GlobeNewswire

    Performance

    YTD
    +53.05%
    +53.05%
    1 Month
    +60.72%
    +60.72%
    3 Month
    +69.43%
    +69.43%
    6 Month
    +112.32%
    +112.32%
    1 Year
    +75.05%
    +75.05%

    More News

    Read More
    S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
    Via Benzinga
    Earnings Scheduled For February 6, 2024
    Via Benzinga
    Earnings Outlook For Deciphera Pharmaceuticals
    Via Benzinga
    Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Why Is Mullen Automotive (MULN) Stock Up 27% Today?
    Via InvestorPlace
    Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Citi Just Raised Its Price Target on Shopify (SHOP) Stock
    Via InvestorPlace
    Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?
    Via InvestorPlace
    Dow Surges Over 100 Points; Domino's Pizza Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion
    Via Investor's Business Daily
    DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
    From Deciphera Pharmaceuticals, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.